|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe显示文摘 | KOSOGLOU T STATKEVICH P FRUCHART J C | 2004 | Gurr Med Res Opin2004，20，8： | 1 |
| 2 | Absorption, metabolism, and excretion of 14C - temozolomide follow- ing oral administration to patients with advanced cancer 显示文摘 | Baker SD Wirth M Statkevich P | 1999 | Clin Cancer Res1999，5，2： | 1 |
| 3 | Absorption,metabolism and excretion of 14C-temozolomide following oral administration to patients with advanced cancer显示文摘 | Baker SD Wirth M Statkevich P | 1999 | Clin Cancer Res1999，5，： | 1 |
| 4 | Renal disposition and drug interaction screening of 2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney 显示文摘 | Sweeney KR Hsyu PH Statkevich P | 1995 | Pharm Res1995，12，12： | 1 |
| 5 | Absorption, metabolism,and excretion of 14C-temozolomide following oral adimministration to patients with advanced cancer显示文摘 | Wirthm Statkevich P | 1999 | Clin Cancer Res1999，5，2： | 1 |
| 6 | Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil 显示文摘 | Reyderutan L Kosoglou T Statkevich P | 2004 | Int J Clin Pharmacol Ther2004，42，9： | 1 |
| 7 | EZE:a review of its metabolism,pharmacokinetics and drug interactions显示文摘 | KOSOGLOU T STATKEVICH P JOHNSON-LEVONAS A O | 2005 | Clinical Pharmacokinetics2005，44，5： | 1 |
| 8 | Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin 显示文摘 | Kosoglou T Statkevich P Meyer I | 2004 | Curr Med Res Opin2004，20，6： | 1 |
| 9 | Assessment of a multiple-dose drug interaction between ezetimibe,a novel selective cholesterol absorption inhibitor and gemfibrozil显示文摘 | Reyderman L Kosoglou T Statkevich P | 2004 | Int J Clin Pharmacol Ther2004，42，9： | 1 |
| 10 | Assess- ment of the pharmacokinetic (PK), pharmacodynamic (PD) interaction potential between posaconazole and glipizide in healthy volunteers显示文摘 | COURTNEY R SANSONE A STATKEVICH P | 2003 | Clinical Pharmacology & Therapeutics2003，73，2： | 1 |
| 11 | Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions显示文摘 | KOSOGLOU T STATKEVICH P JOHNSON-LEVONAS AO | 2005 | Clin Pharmacokinet2005，44，5： | 1 |
| 12 | Ezetimibe:a re-view of its metabolism, pharmacokinetics and drug interactions显示文摘 | Kosoglou T Statkevich P Johnson-Levonas AO | 2005 | Clin Phamacokinet2005，44，5： | 1 |
| 13 | Pharmaco- dynamic and pharmacok'metic interaction between fenofibrate and ezetimibe 显示文摘 | Kosoglou T Statkevich P Fruchart J C | 2004 | Curt Med Res2004，20，： | 1 |
| 14 | Phar-macokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment显示文摘 | STATKEVICH P KOSOGLOU T PRESTON RA | 2012 | Eur J Clin Pharmacol2012，68，11： | 1 |
| 15 | Evaluation of the exposure equivalence of oral versus intravenous temozolomlde 显示文摘 | DIEZ BD STATKEVICH P ZHU Y | 2010 | Cancer ChemotherPharm2010，65，4： | 1 |
| 16 | The effect of multiple doses of ketoconazole or rifampin on the single- and multiple-dose pharmacokinetics of vorapaxar显示文摘 | KOSOGLOU T STATKEVICH P KUMAR B | 2013 | J Clin Pharma- col2013，53，5： | 1 |
| 17 | Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe显示文摘 | KOSOGLOU T STATKEVICH P FRUCHART JC | 2004 | Curr Med Res Opin2004，20，8： | 1 |
| 18 | Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer 显示文摘 | BAKER S D WIRTH M STATKEVICH P | 1999 | Clin Cancer Res1999，5，： | 1 |
| 19 | Pharmacokinetics of ezetimibe in rats,dogs and humans显示文摘 | Statkevich P Schuessler D | 2000 | AAPS Pharm Sci2000，2，4： | 1 |
| 20 | Absorption, metabolism, and excretion of 14 C-temozolomide following oral administration to patients with advanced cancer显示文摘 | Baker SD Wirth M Statkevich P | 1999 | Clin Cancer Res1999，5，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员